Access to generic drugs in the 1950s: the politics of a social problem
From the published literature of the 1950s, the social history of anti-substitution law is analyzed in terms of sociological theory on the construction of social problems. The analysis reveals how the substitution of generic drugs for prescribed brands came to be recognized as a social problem in ne...
Gespeichert in:
| Veröffentlicht in: | American journal of public health (1971) 1982-05, Vol.72 (5), p.468-475 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 475 |
|---|---|
| container_issue | 5 |
| container_start_page | 468 |
| container_title | American journal of public health (1971) |
| container_volume | 72 |
| creator | Facchinetti, N J Dickson, W M |
| description | From the published literature of the 1950s, the social history of anti-substitution law is analyzed in terms of sociological theory on the construction of social problems. The analysis reveals how the substitution of generic drugs for prescribed brands came to be recognized as a social problem in need of remedial legislation. The most influential party in the process was the brand-drug industry which centered the debate on matters of public health and professionalism instead of industrial profitability. The industry was able to form a coalition of interests and establish the saliency and legitimacy of the problem, even though there was no objective evidence to establish brand substitution as a hazard to health. The case fits well into the theory of social problem construction. Other issues in health care, particularly drug issues can be studied from this same perspective. |
| doi_str_mv | 10.2105/AJPH.72.5.468 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1649781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>13734202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-8dbd8d5944eea429aff10cee6f1592b7df9d21943573c7a2fb50ec3824345fed3</originalsourceid><addsrcrecordid>eNqFkc2L1EAQxRtR1nH16FFoELxl7OqPdNqDMCyuqyzoQc9Np1OZ9JCkY3ei-N-bcYfx47KnKqgfj1fvEfIc2JYDU693Hz_fbDXfqq0sqwdkA0pCwZisHpINY4atuygfkyc5HxgDMAouyIVmpRJCbcj1znvMmc6R7nHEFDxt0rLPNIx07pCuPMtvfq9T7MMcfKaxpY7m6IPr6ZRi3ePwlDxqXZ_x2Wlekq_X775c3RS3n95_uNrdFl4xMRdVUzdVo4yUiE5y49oWmEcsW1CG17ppTcPBSKG08NrxtlYMvai4FFK12IhL8vZOd1rqARuP45xcb6cUBpd-2uiC_fcyhs7u43cLpTS6glXg1UkgxW8L5tkOIXvsezdiXLLVwmjDlbkXhGp1XCl1Pyi0kJzxFXz5H3iISxrXuCxwUwnQAEeDxR3lU8w5YXt-Dpg9Fm6PhVvNrbJr4Sv_4u9EzvSp4T_2urDvfoSENg-u71carDtM3VnoF-j-sgc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1298317111</pqid></control><display><type>article</type><title>Access to generic drugs in the 1950s: the politics of a social problem</title><source>PubMed (Medline)</source><source>MEDLINE</source><source>EBSCOhost Education Source</source><source>Business Source Complete</source><source>Alma/SFX Local Collection</source><source>Periodicals Index Online</source><creator>Facchinetti, N J ; Dickson, W M</creator><creatorcontrib>Facchinetti, N J ; Dickson, W M</creatorcontrib><description>From the published literature of the 1950s, the social history of anti-substitution law is analyzed in terms of sociological theory on the construction of social problems. The analysis reveals how the substitution of generic drugs for prescribed brands came to be recognized as a social problem in need of remedial legislation. The most influential party in the process was the brand-drug industry which centered the debate on matters of public health and professionalism instead of industrial profitability. The industry was able to form a coalition of interests and establish the saliency and legitimacy of the problem, even though there was no objective evidence to establish brand substitution as a hazard to health. The case fits well into the theory of social problem construction. Other issues in health care, particularly drug issues can be studied from this same perspective.</description><identifier>ISSN: 0090-0036</identifier><identifier>EISSN: 1541-0048</identifier><identifier>DOI: 10.2105/AJPH.72.5.468</identifier><identifier>PMID: 7065335</identifier><language>eng</language><publisher>United States: Am Public Health Assoc</publisher><subject>Drug Industry ; Legislation, Pharmacy ; Social Problems ; Societies, Pharmaceutical ; Therapeutic Equivalency ; United States ; United States Food and Drug Administration</subject><ispartof>American journal of public health (1971), 1982-05, Vol.72 (5), p.468-475</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-8dbd8d5944eea429aff10cee6f1592b7df9d21943573c7a2fb50ec3824345fed3</citedby><cites>FETCH-LOGICAL-c503t-8dbd8d5944eea429aff10cee6f1592b7df9d21943573c7a2fb50ec3824345fed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1649781/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1649781/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27869,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7065335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Facchinetti, N J</creatorcontrib><creatorcontrib>Dickson, W M</creatorcontrib><title>Access to generic drugs in the 1950s: the politics of a social problem</title><title>American journal of public health (1971)</title><addtitle>Am J Public Health</addtitle><description>From the published literature of the 1950s, the social history of anti-substitution law is analyzed in terms of sociological theory on the construction of social problems. The analysis reveals how the substitution of generic drugs for prescribed brands came to be recognized as a social problem in need of remedial legislation. The most influential party in the process was the brand-drug industry which centered the debate on matters of public health and professionalism instead of industrial profitability. The industry was able to form a coalition of interests and establish the saliency and legitimacy of the problem, even though there was no objective evidence to establish brand substitution as a hazard to health. The case fits well into the theory of social problem construction. Other issues in health care, particularly drug issues can be studied from this same perspective.</description><subject>Drug Industry</subject><subject>Legislation, Pharmacy</subject><subject>Social Problems</subject><subject>Societies, Pharmaceutical</subject><subject>Therapeutic Equivalency</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>0090-0036</issn><issn>1541-0048</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNqFkc2L1EAQxRtR1nH16FFoELxl7OqPdNqDMCyuqyzoQc9Np1OZ9JCkY3ei-N-bcYfx47KnKqgfj1fvEfIc2JYDU693Hz_fbDXfqq0sqwdkA0pCwZisHpINY4atuygfkyc5HxgDMAouyIVmpRJCbcj1znvMmc6R7nHEFDxt0rLPNIx07pCuPMtvfq9T7MMcfKaxpY7m6IPr6ZRi3ePwlDxqXZ_x2Wlekq_X775c3RS3n95_uNrdFl4xMRdVUzdVo4yUiE5y49oWmEcsW1CG17ppTcPBSKG08NrxtlYMvai4FFK12IhL8vZOd1rqARuP45xcb6cUBpd-2uiC_fcyhs7u43cLpTS6glXg1UkgxW8L5tkOIXvsezdiXLLVwmjDlbkXhGp1XCl1Pyi0kJzxFXz5H3iISxrXuCxwUwnQAEeDxR3lU8w5YXt-Dpg9Fm6PhVvNrbJr4Sv_4u9EzvSp4T_2urDvfoSENg-u71carDtM3VnoF-j-sgc</recordid><startdate>19820501</startdate><enddate>19820501</enddate><creator>Facchinetti, N J</creator><creator>Dickson, W M</creator><general>Am Public Health Assoc</general><general>American Public Health Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HDMVH</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>7TS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19820501</creationdate><title>Access to generic drugs in the 1950s: the politics of a social problem</title><author>Facchinetti, N J ; Dickson, W M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-8dbd8d5944eea429aff10cee6f1592b7df9d21943573c7a2fb50ec3824345fed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Drug Industry</topic><topic>Legislation, Pharmacy</topic><topic>Social Problems</topic><topic>Societies, Pharmaceutical</topic><topic>Therapeutic Equivalency</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Facchinetti, N J</creatorcontrib><creatorcontrib>Dickson, W M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 15</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of public health (1971)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Facchinetti, N J</au><au>Dickson, W M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Access to generic drugs in the 1950s: the politics of a social problem</atitle><jtitle>American journal of public health (1971)</jtitle><addtitle>Am J Public Health</addtitle><date>1982-05-01</date><risdate>1982</risdate><volume>72</volume><issue>5</issue><spage>468</spage><epage>475</epage><pages>468-475</pages><issn>0090-0036</issn><eissn>1541-0048</eissn><abstract>From the published literature of the 1950s, the social history of anti-substitution law is analyzed in terms of sociological theory on the construction of social problems. The analysis reveals how the substitution of generic drugs for prescribed brands came to be recognized as a social problem in need of remedial legislation. The most influential party in the process was the brand-drug industry which centered the debate on matters of public health and professionalism instead of industrial profitability. The industry was able to form a coalition of interests and establish the saliency and legitimacy of the problem, even though there was no objective evidence to establish brand substitution as a hazard to health. The case fits well into the theory of social problem construction. Other issues in health care, particularly drug issues can be studied from this same perspective.</abstract><cop>United States</cop><pub>Am Public Health Assoc</pub><pmid>7065335</pmid><doi>10.2105/AJPH.72.5.468</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-0036 |
| ispartof | American journal of public health (1971), 1982-05, Vol.72 (5), p.468-475 |
| issn | 0090-0036 1541-0048 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1649781 |
| source | PubMed (Medline); MEDLINE; EBSCOhost Education Source; Business Source Complete; Alma/SFX Local Collection; Periodicals Index Online |
| subjects | Drug Industry Legislation, Pharmacy Social Problems Societies, Pharmaceutical Therapeutic Equivalency United States United States Food and Drug Administration |
| title | Access to generic drugs in the 1950s: the politics of a social problem |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A12%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Access%20to%20generic%20drugs%20in%20the%201950s:%20the%20politics%20of%20a%20social%20problem&rft.jtitle=American%20journal%20of%20public%20health%20(1971)&rft.au=Facchinetti,%20N%20J&rft.date=1982-05-01&rft.volume=72&rft.issue=5&rft.spage=468&rft.epage=475&rft.pages=468-475&rft.issn=0090-0036&rft.eissn=1541-0048&rft_id=info:doi/10.2105/AJPH.72.5.468&rft_dat=%3Cproquest_pubme%3E13734202%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1298317111&rft_id=info:pmid/7065335&rfr_iscdi=true |